(Q40471190)

20 September 2017

1 reference

title

Amphotericin B toxicity reduced by administration in fat emulsion. (English)

1 reference

20 September 2017

1 reference

R P Anderson

1

1 reference

20 September 2017

D A Clark

series ordinal

2

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 May 1995

1 reference

Annals of Pharmacotherapy

20 September 2017

published in

1 reference

20 September 2017

volume

29

1 reference

20 September 2017

issue

5

1 reference

20 September 2017

page(s)

496-500

1 reference

Trial of glucose versus fat emulsion in preparation of amphotericin for use in HIV infected patients with candidiasis

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900509

Clinical evaluation of a new lipid-based delivery system for intravenous administration of amphotericin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900509

Reduced renal toxicity and improved clinical tolerance of amphotericin B mixed with intralipid compared with conventional amphotericin B in neutropenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900509

Efficacy and tolerance of an amphotericm B lipid (Intralipid) emulsion in the treatment of candidaemia in neutropenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900509

Liposomal and lipid formulations of amphotericin B. Clinical pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900509

Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900509

Treatment of hepatosplenic candidiasis with liposomal-amphotericin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900509

An emulsion formulation of amphotericin B improves the therapeutic index when treating systemic murine candidiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900509

Cardiopulmonary toxicity after liposomal amphotericin B infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900509

10.1177/106002809502900509

21 January 2018

Identifiers

DOI

1 reference

20 September 2017

1 reference